Federated Hermes
DCPH icon

Federated Hermes’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Federated Hermes’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-240,762
Closed -$3.95M – 2294
2022
Q4 		$3.95M Sell
240,762
-7,404
-3% -$120K 0.01% 728
2022
Q3 		$4.59M Sell
248,166
-689,151
-74% -$10.8M 0.01% 691
2022
Q2 		$12.3M Sell
937,317
-1,021,761
-52% -$11.3M 0.03% 507
2022
Q1 		$18.2M Buy
1,959,078
+1,090,368
+126% +$9.27M 0.04% 472
2021
Q4 		$8.49M Buy
+868,710
New +$16.3M 0.02% 693
2021
Q1 		– Sell
-7,177
Closed -$410K – 2368
2020
Q4 		$410K Buy
7,177
+7,137
+17,843% +$423K ﹤0.01% 1565
2020
Q3 		$2K Sell
40
-2,315
-98% -$113K ﹤0.01% 2114
2020
Q2 		$141K Sell
2,355
-196,148
-99% -$10.5M ﹤0.01% 1668
2020
Q1 		$8.17M Sell
198,503
-39,774
-17% -$2.21M 0.02% 523
2019
Q4 		$14.8M Buy
238,277
+230,033
+2,790% +$10.9M 0.03% 501
2019
Q3 		$280K Buy
+8,244
New +$244K ﹤0.01% 1537
2018
Q4 		– Sell
-28,756
Closed -$1.11M – 2334
2018
Q3 		$1.11M Buy
+28,756
New +$1.06M ﹤0.01% 1319

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Federated Hermes's DCPH Position: Q1 2023 in Review

Federated Hermes sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q1 2023, closing a stake of 240,762 shares — an estimated $3.95M sold.

Federated Hermes first reported a position in DCPH in Q3 2018 and held it in 12 quarters. The position peaked at $18.2M in Q1 2022. 146 funds tracked by Wall St. Rank hold DCPH as of Q1 2023.

  • Federated Hermes reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Federated Hermes sold 240,762 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q1 2023, an estimated $3.95M.
  • Federated Hermes first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • Federated Hermes's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $18.2M in Q1 2022.
  • 146 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q1 2023.

Based on Federated Hermes's 13F filing for Q1 2023, filed 8 May 2023.